DelphX Capital Markets completed a non-brokered private placement raising C$61,000 by issuing 6.1 million units at C$0.01 each. Each unit includes one common share and a warrant to buy another share at C$0.06 within two years. An insider subscribed for 500,000 units, making this a related party transaction under TSXV rules. The funds will support working capital and corporate overhead as DelphX advances its structured products business, pending TSXV approval and subject to standard hold periods.
DelphX Capital Markets' recent private placement is presented here with Pluang's Financials-sector market data for context. For readers following Financials, of 84 priced US stocks on Pluang, 31 rose and 52 fell. Notable movers include Nasdaq Inc (NDAQ) at USD 96.34 with a 1-day change of +1.95% and typical hold time of 124 days, Prudential PLC (PUK) at USD 25.37 down 1.86%, and Barclays PLC (BCS) at USD 24.54 down 1.72% with a 72% sell order activity. Data as of Sep 23, 2026 21:51 WIB.
Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...
BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...
Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...
Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...
Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...
